Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REACT-MI: Tailored Antiplatelet Therapy in AMI
NCT01381185Phase 4Completed
- Sponsor
- University Hospital Ostrava
- Start
- May 2011
- Primary completion
- Jun 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label trial of aspirin and clopidogrel in acute myocardial infarction (AMI) (2 arms), sponsored by University Hospital Ostrava. Primary endpoint: Platelet inhibition level at 5 days. Started May 2011; status: completed.
02
Drugs
aspirinclopidogrel
03
Conditions
acute myocardial infarction (AMI)
Beyond the preview
Go deeper on NCT01381185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01381185.